Hydroxychloroquine Dose per Ophthalmology Guidelines and the Risk of Systemic Lupus Erythematosus Flares

This study of an academic medical center patient cohort with systemic lupus erythematosus (SLE) investigates the association between hydroxychloroquine dose based on current guidelines and risk of lupus flares.

Saved in:
Bibliographic Details
Published in:JAMA : the journal of the American Medical Association 2022-10, Vol.328 (14), p.1458-1460
Main Authors: Jorge, April M, Mancini, Christian, Zhou, Baijun, Ho, Gary, Zhang, Yuqing, Costenbader, Karen, Choi, Hyon K
Format: Article
Language:English
Subjects:
Antirheumatic Agents - adverse effects
Antirheumatic Agents - therapeutic use
Chronic conditions
Comments
Dosage
Dose-Response Relationship, Drug
Eye Diseases - chemically induced
Flares
Guidelines
Humans
Hydroxychloroquine
Hydroxychloroquine - administration & dosage
Hydroxychloroquine - adverse effects
Letter
Letters
Lupus
Lupus Erythematosus, Systemic - drug therapy
Lupus Erythematosus, Systemic - prevention & control
Online First
Ophthalmology
Ophthalmology - standards
Practice Guidelines as Topic - standards
Research Letter
Retinopathy
Rheumatology
Risk
Symptom Flare Up
Systemic lupus erythematosus
Toxicity
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This study of an academic medical center patient cohort with systemic lupus erythematosus (SLE) investigates the association between hydroxychloroquine dose based on current guidelines and risk of lupus flares.
ISSN:0098-7484
1538-3598
DOI:10.1001/jama.2022.13591